This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Oxford Cannabinoid Technologies Holdings Future Growth
Future criteria checks 0/6
Oxford Cannabinoid Technologies Holdings is forecast to grow earnings at 15.1% per annum. EPS is expected to grow by 24.1% per annum.
Key information
15.1%
Earnings growth rate
24.1%
EPS growth rate
| Pharmaceuticals earnings growth | 19.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Feb 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 4/30/2025 | N/A | -3 | N/A | N/A | 1 |
| 4/30/2024 | N/A | -2 | N/A | N/A | 1 |
| 10/31/2023 | N/A | -4 | -4 | -4 | N/A |
| 7/31/2023 | N/A | -5 | -5 | -5 | N/A |
| 4/30/2023 | N/A | -6 | -7 | -7 | N/A |
| 4/30/2022 | N/A | -5 | -6 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OCTP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OCTP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OCTP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if OCTP's revenue is forecast to grow faster than the UK market.
High Growth Revenue: OCTP is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OCTP's Return on Equity is forecast to be high in 3 years time